Cargando…
Faricimab for Treatment-Resistant Diabetic Macular Edema
PURPOSE: To assess the short-term outcomes in treatment-resistant diabetic macular edema (DME) patients changed from intravitreal aflibercept (IVA) to intravitreal faricimab (IVF). METHODS: A retrospective review was undertaken on DME subjects receiving IVA therapy at a single private practice. Pati...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420435/ https://www.ncbi.nlm.nih.gov/pubmed/36042912 http://dx.doi.org/10.2147/OPTH.S381503 |